J Endocr Surg.  2019 Mar;19(1):1-10. 10.16956/jes.2019.19.1.1.

Risk Factors for Distant Metastasis in Follicular Thyroid Carcinoma in Korea

• Jo SD
• Lee JH
• Kang SH
• Kim YY
• Chun YS
• Park HK
• Choi ST
• Kang JM
• Chung YS

• KMID: 2442155
• DOI: http://doi.org/10.16956/jes.2019.19.1.1

Abstract

PURPOSE
Follicular thyroid cancer (FTC) can frequently metastasize to distant organs, which worsens the prognosis. This study evaluated the risk factors of distant metastasis in FTC.
METHODS
We retrospectively reviewed 149 patients diagnosed with primary FTC and underwent operations between 2001 and 2017.
RESULTS
The mean age of all patients was 44.8±14.4 years and 82.6% were female. The mean tumor size was 3.44±1.77 cm and a total thyroidectomy was performed in 41.6% of cases. The follow-up duration was 65.4±43.5 months. Distant metastases occurred in 8 patients (5.4%): 5 patients had synchronous and 3 had metachronous distant metastasis. The most common metastatic site was the bone, with bone metastasis observed in 5 of 8 patients, followed by the lung (3 of 8). Bone metastases occurred in 4 of 5 patients with synchronous distant metastasis and in 1 of 3 with metachronous distant metastasis. Distant metastasis was associated with old age (≥45 years), the presence of vascular invasion, widely invasive FTC, and high thyroglobulin (Tg) levels in the first postoperative month. Multivariate analysis showed that old age and the presence of vascular invasion were predictive factors for distant metastasis (P=0.016 and P=0.013, respectively).
CONCLUSION
Old age and vascular invasion were significant factors for distant metastasis. The possibility of bone and lung distant metastases should be assessed when a patient is old (≥45 years), FTC is widely invasive, and when Tg levels are high in the first postoperative month.

Keyword

Follicular thyroid carcinoma; Metastasis; Prognostic factor; Age of onset; Prognosis

MeSH Terms

Adenocarcinoma, Follicular*
Age of Onset
Female
Follow-Up Studies
Humans
Korea*
Lung
Multivariate Analysis
Neoplasm Metastasis*
Prognosis
Retrospective Studies
Risk Factors*
Thyroglobulin
Thyroid Neoplasms
Thyroidectomy
Thyroglobulin

Reference

1. Townsend CM Jr, Beauchamp RD, Evers BM, Mattox KL. Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 20th ed. Philadelphia (PA): Elsevier Saunders;2016.

2. Korea Central Cancer Registry. National Cancer Center (KR). Ministry of Health and Welfare (KR). Annual Report of Cancer Statistics in Korea in 2015. Goyang: Korea Central Cancer Registry;2017.

3. Lloyd RV, Osamura RY, Klöppel G, Rosai J. WHO Classification of Tumours of Endocrine Organs. 4th ed. Lyon: International Agency for Research on Cancer;2017.

4. McHenry CR, Phitayakorn R. Follicular adenoma and carcinoma of the thyroid gland. Oncologist. 2011; 16:585–593.

5. Sampson E, Brierley JD, Le LW, Rotstein L, Tsang RW. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis. Cancer. 2007; 110:1451–1456.

6. Kim H, Kim HI, Kim SW, Jung J, Jeon MJ, Kim WG, et al. Prognosis of differentiated thyroid carcinoma with initial distant metastasis: a multicenter study in Korea. Endocrinol Metab (Seoul). 2018; 33:287–295.

7. Shimbashi W, Sugitani I, Kawabata K, Mitani H, Toda K, Yamada K, et al. Thick tumor capsule is a valuable risk factor for distant metastasis in follicular thyroid carcinoma. Auris Nasus Larynx. 2018; 45:147–155.

8. Leite AK, Cavalheiro BG, Kulcsar MA, Hoff AO, Brandão LG, Cernea CR, et al. Deaths related to differentiated thyroid cancer: a rare but real event. Arch Endocrinol Metab. 2017; 61:222–227.

9. Sugino K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, et al. Prognosis and prognostic factors for distant metastases and tumor mortality in follicular thyroid carcinoma. Thyroid. 2011; 21:751–757.

10. Ito Y, Hirokawa M, Masuoka H, Yabuta T, Kihara M, Higashiyama T, et al. Prognostic factors of minimally invasive follicular thyroid carcinoma: extensive vascular invasion significantly affects patient prognosis. Endocr J. 2013; 60:637–642.

11. Ju YW, Kim SJ, Chai YJ, Yi JW, Seong CY, Kim JK, et al. Clinicopathologic features in minimally invasive follicular thyroid cancer patients with distant metastasis. Korean J Endocr Surg. 2016; 16:100–106.

12. Sung MK, Lee YM, Sung TY, Yoon JH, Chung KW, Hong SJ. Risk factors for distant metastasis in patients with follicular thyroid carcinoma. Korean J Endocr Surg. 2016; 16:25–30.

13. Lee YM, Sung TY, Yoon JH, Chung KW, Hong SJ. Long term outcome of minimally invasive follicular thyroid carcinoma according to risk group stratification. J Endocr Surg. 2018; 18:183–190.

14. Kim WW, Hur SM, Kim SH, Lee SK, Kim S, Oh YL, et al. Prognostic factors and treatment in follicular thyroid carcinoma. J Korean Surg Soc. 2010; 78:149–156.

15. Lee YM, Song DE, Kim TY, Sung TY, Yoon JH, Chung KW, et al. Risk factors for distant metastasis in patients with minimally invasive follicular thyroid carcinoma. PLoS One. 2016; 11:e0155489.

16. Lee YM, Lee YH, Song DE, Kim WB, Sung TY, Yoon JH, et al. Prognostic impact of further treatments on distant metastasis in patients with minimally invasive follicular thyroid carcinoma: verification using inverse probability of treatment weighting. World J Surg. 2017; 41:138–145.

17. Sugino K, Kameyama K, Ito K, Nagahama M, Kitagawa W, Shibuya H, et al. Outcomes and prognostic factors of 251 patients with minimally invasive follicular thyroid carcinoma. Thyroid. 2012; 22:798–804.

18. Stenson G, Nilsson IL, Mu N, Larsson C, Lundgren CI, Juhlin CC, et al. Minimally invasive follicular thyroid carcinomas: prognostic factors. Endocrine. 2016; 53:505–511.

19. Lee J, Soh EY. Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors. Ann Surg. 2010; 251:114–119.

20. Parameswaran R, Shulin Hu J, Min En N, Tan WB, Yuan NK. Patterns of metastasis in follicular thyroid carcinoma and the difference between early and delayed presentation. Ann R Coll Surg Engl. 2017; 99:151–154.

21. D'Avanzo A, Treseler P, Ituarte PH, Wong M, Streja L, Greenspan FS, et al. Follicular thyroid carcinoma: histology and prognosis. Cancer. 2004; 100:1123–1129.

22. Wu K, Hou SM, Huang TS, Yang RS. Thyroid carcinoma with bone metastases: a prognostic factor study. Clin Med Oncol. 2008; 2:129–134.

23. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016; 26:1–133.

24. O'Neill CJ, Vaughan L, Learoyd DL, Sidhu SB, Delbridge LW, Sywak MS. Management of follicular thyroid carcinoma should be individualised based on degree of capsular and vascular invasion. Eur J Surg Oncol. 2011; 37:181–185.

25. Goffredo P, Cheung K, Roman SA, Sosa JA. Can minimally invasive follicular thyroid cancer be approached as a benign lesion?: a population-level analysis of survival among 1,200 patients. Ann Surg Oncol. 2013; 20:767–772.